Nanopublications

Matches in Nanopublications for { ?s ?p "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 100 of ±164 with 100 items per page.

NP69569.RAeF9TI3rVe8Ii5lGFuQRIEmDnReRNAjYaEbVE8UZ20Xg130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP69569.RAeF9TI3rVe8Ii5lGFuQRIEmDnReRNAjYaEbVE8UZ20Xg130_provenance.
NP76304.RAYBBRlZ1Pjbjo_BHDkptCoDap9NaJQ_JVWttjyhavUeQ130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP76304.RAYBBRlZ1Pjbjo_BHDkptCoDap9NaJQ_JVWttjyhavUeQ130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP89103.RAjGB7aGgdahykq9WJWgZtN3ZAPzJp_oiwO3t9cvgqBPg130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89103.RAjGB7aGgdahykq9WJWgZtN3ZAPzJp_oiwO3t9cvgqBPg130_provenance.
NP83056.RAL_M_2e_uDXeMhwCKvywQM1uZUgIMmq4EKqHpfKQc67U130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83056.RAL_M_2e_uDXeMhwCKvywQM1uZUgIMmq4EKqHpfKQc67U130_provenance.
NP81597.RAB7Rmjf5lXotoD_qJ8FOUV0IbV1JpJBQ-cGjFS0nX5Dw130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP81597.RAB7Rmjf5lXotoD_qJ8FOUV0IbV1JpJBQ-cGjFS0nX5Dw130_provenance.
NP83087.RAAw-HPn9JfhLXxF4TNDQFsp7sBXucp-oHC6RKIJkgc1k130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83087.RAAw-HPn9JfhLXxF4TNDQFsp7sBXucp-oHC6RKIJkgc1k130_provenance.
NP83603.RACz9ulR1QaA4sGY5hsYho-13FuxdZIG_UKv6U1kIAJQk130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83603.RACz9ulR1QaA4sGY5hsYho-13FuxdZIG_UKv6U1kIAJQk130_provenance.
NP86328.RADwr444UfoOhzcDVAy5pzTFKsh8sYeqZ0LcEFMN6mL-E130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86328.RADwr444UfoOhzcDVAy5pzTFKsh8sYeqZ0LcEFMN6mL-E130_provenance.
NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP74729.RA7Yge4L2ot9a0n2kbLHlK9pU7E0_534GwNc6j6CzWSek130_provenance.
NP82933.RA5PQFIbsGd_54I7xg8XLh6Ax6LJ23C6Ta60PD9QOeM0I130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82933.RA5PQFIbsGd_54I7xg8XLh6Ax6LJ23C6Ta60PD9QOeM0I130_provenance.
NP82949.RA5JJEpvKcNevj6LVzmfJqMqQ55ATOF2nb57oMKarYSjE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82949.RA5JJEpvKcNevj6LVzmfJqMqQ55ATOF2nb57oMKarYSjE130_provenance.
NP85510.RA_zyklYxRPO4LvBwNX4UrHxXHQoIYDErAbU3F0zzdN4U130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85510.RA_zyklYxRPO4LvBwNX4UrHxXHQoIYDErAbU3F0zzdN4U130_provenance.
NP85583.RAziONtFb5BYoSle5h8eYIPEPcKXsD6zqB6C0puuyvQ9U130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85583.RAziONtFb5BYoSle5h8eYIPEPcKXsD6zqB6C0puuyvQ9U130_provenance.
NP86228.RAxlqwukgLDzAXNm2DcUKmDamTUHS4MbX1FDpJNydZXZs130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86228.RAxlqwukgLDzAXNm2DcUKmDamTUHS4MbX1FDpJNydZXZs130_provenance.
NP86342.RA9Z1ZGSXnw40bsmPKQl0A6GyuIOXY4wVN8lTp-tFgtcw130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86342.RA9Z1ZGSXnw40bsmPKQl0A6GyuIOXY4wVN8lTp-tFgtcw130_provenance.
NP87097.RAzmirWHkSO4-bmLXZrvfM6ynKut0LlhcYm5c3tpoJqAU130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87097.RAzmirWHkSO4-bmLXZrvfM6ynKut0LlhcYm5c3tpoJqAU130_provenance.
NP87662.RAy7a_LE6r_V9LK4PkR5Fwhchws2TPmvbfCWZI3iVHJXg130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP87662.RAy7a_LE6r_V9LK4PkR5Fwhchws2TPmvbfCWZI3iVHJXg130_provenance.
NP89100.RA2yVqFK6M0kOf97F84oo51lgtAzL0GAUUVBCbLWYWj4c130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89100.RA2yVqFK6M0kOf97F84oo51lgtAzL0GAUUVBCbLWYWj4c130_provenance.
NP90981.RAwsa3K4nFQtoBUjvB2oHi1rJ8u65nPrctozWkhpRjYZ4130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90981.RAwsa3K4nFQtoBUjvB2oHi1rJ8u65nPrctozWkhpRjYZ4130_provenance.
NP90991.RA-xopcs9CGS-klhkenOPsOqvUFFx2M2QBvK8InBC-S3U130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90991.RA-xopcs9CGS-klhkenOPsOqvUFFx2M2QBvK8InBC-S3U130_provenance.
NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86881.RAQVjLy4pf2UINXbJBRQ0flqaqVF1Ovn8q5U_3ShMxI6g130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP91700.RAfFmE-9quzBnmH9AWw268Ae0F2h5OPXBWUYCIyzPbljg130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91700.RAfFmE-9quzBnmH9AWw268Ae0F2h5OPXBWUYCIyzPbljg130_provenance.
NP91739.RAYu3w9k7A5d5f6lu--IVY8pql2T4KOTOXtWrE5RuOwMM130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91739.RAYu3w9k7A5d5f6lu--IVY8pql2T4KOTOXtWrE5RuOwMM130_provenance.
NP86196.RAiC2qJnNbvUfNl9gWs3IoItJP_Wwthsq-PMl2kRVtijI130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86196.RAiC2qJnNbvUfNl9gWs3IoItJP_Wwthsq-PMl2kRVtijI130_provenance.
NP86211.RAuU8iiPDbGv7GZSQEFVRKmpzVlD_Q2qDRtac8kLAYXyI130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86211.RAuU8iiPDbGv7GZSQEFVRKmpzVlD_Q2qDRtac8kLAYXyI130_provenance.
NP86327.RArJLxx7ncvPeRI_2IMJXIibQsNnTqNNvOnZtKPL8X7gk130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86327.RArJLxx7ncvPeRI_2IMJXIibQsNnTqNNvOnZtKPL8X7gk130_provenance.
NP86389.RAqbd4r03of74NU5inrQKm2TbcSkb25tZXLreLUkKtCwk130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86389.RAqbd4r03of74NU5inrQKm2TbcSkb25tZXLreLUkKtCwk130_provenance.
NP86412.RAuzq6Q1eY-995h7H_ceD4izVUVru8taaW0_NCkQpTxxw130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86412.RAuzq6Q1eY-995h7H_ceD4izVUVru8taaW0_NCkQpTxxw130_provenance.
NP90986.RAvyEgc3ReSS7wETCi0WJOl3xbAIVnwepYRV6-s_xsrmA130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90986.RAvyEgc3ReSS7wETCi0WJOl3xbAIVnwepYRV6-s_xsrmA130_provenance.
NP90996.RAtX6hKcLxG1HaePyYpNSqMvPIqjmFGBlK3obAqUoJfmE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90996.RAtX6hKcLxG1HaePyYpNSqMvPIqjmFGBlK3obAqUoJfmE130_provenance.
NP91448.RAvnCLatNihBdvzIkkK0Psiycab_1uXd_7WR1WNmA97PE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91448.RAvnCLatNihBdvzIkkK0Psiycab_1uXd_7WR1WNmA97PE130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP82937.RAhPX90IuL02U9EXY5AGpxqh-HZHbVqDjPP2DCdcVGJk0130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP82937.RAhPX90IuL02U9EXY5AGpxqh-HZHbVqDjPP2DCdcVGJk0130_provenance.
NP83512.RAjBt5E5X0s0E7lFmHbHAkid2vxj0Yrz00ihz4DhmaXX8130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP83512.RAjBt5E5X0s0E7lFmHbHAkid2vxj0Yrz00ihz4DhmaXX8130_provenance.
NP85364.RAq8MB7eBoeBPbK2MWYo0DvYzLNm7NbOoA_iW_q2GmYzo130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP85364.RAq8MB7eBoeBPbK2MWYo0DvYzLNm7NbOoA_iW_q2GmYzo130_provenance.
NP92643.RAqjOadw6eD57IZAJ56kMpnFZB8h9RNe5BBvqrvgGG2V8130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92643.RAqjOadw6eD57IZAJ56kMpnFZB8h9RNe5BBvqrvgGG2V8130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP86384.RAPccg7cb1RecLlV6uHfT0mSoVJBzchTFljVVfBHersw4130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86384.RAPccg7cb1RecLlV6uHfT0mSoVJBzchTFljVVfBHersw4130_provenance.
NP90013.RAKPHH8ZhkyfRiL-WqBbx9P_UEbT2swyZobH6uMzojlNU130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90013.RAKPHH8ZhkyfRiL-WqBbx9P_UEbT2swyZobH6uMzojlNU130_provenance.
NP90994.RAELVlzYyK26zo2Mue5Z-s-lZRD-rYA0J13v0xyi-dQaU130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90994.RAELVlzYyK26zo2Mue5Z-s-lZRD-rYA0J13v0xyi-dQaU130_provenance.
NP91001.RANoMgedvyIuiwv5s9sjFVy-az7n6J6Af-d4zfoO8Dm-c130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91001.RANoMgedvyIuiwv5s9sjFVy-az7n6J6Af-d4zfoO8Dm-c130_provenance.
NP91726.RANSbdWoxDO8r5uDQSYz5ksGn8PbyN2v2i65tlVp68uuY130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP91726.RANSbdWoxDO8r5uDQSYz5ksGn8PbyN2v2i65tlVp68uuY130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP92184.RAb-gkiCk5ghD8mh3SJ1cb8Kdp3llQUAobh2YbDmgAdhU130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP92184.RAb-gkiCk5ghD8mh3SJ1cb8Kdp3llQUAobh2YbDmgAdhU130_provenance.
NP97024.RAVnS7CShCZykbj-eL1SUvAhX5ev5mcGOi0JdaZzMbs-A130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97024.RAVnS7CShCZykbj-eL1SUvAhX5ev5mcGOi0JdaZzMbs-A130_provenance.
NP97218.RAdSl7oI4C4IngbVsUzh_YtmNdckmNugZlKZQ6IKAOg-M130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97218.RAdSl7oI4C4IngbVsUzh_YtmNdckmNugZlKZQ6IKAOg-M130_provenance.
NP99964.RAcxABOyUSimr1nvsG-IvO-4ivnAhXEobA1en7sTGrUCo130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP99964.RAcxABOyUSimr1nvsG-IvO-4ivnAhXEobA1en7sTGrUCo130_provenance.
NP101445.RATPUvQNvnNtQPEM2y060cJ5s0k-GH_dV7xEkxGtvTgyE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101445.RATPUvQNvnNtQPEM2y060cJ5s0k-GH_dV7xEkxGtvTgyE130_provenance.
NP101544.RAZPJVWTRon0D6XFnD1Gal2-mZzfZAXhP4iIzTCN3QQJo130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101544.RAZPJVWTRon0D6XFnD1Gal2-mZzfZAXhP4iIzTCN3QQJo130_provenance.
NP118153.RAcshlTLFp8x2Lr0gA374ebX3d9VJUBs7S0tB538OOXSM130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118153.RAcshlTLFp8x2Lr0gA374ebX3d9VJUBs7S0tB538OOXSM130_provenance.
NP121379.RAemdQwDzVZh7gLMbPxLYNNiBsI2mha62xCPOSbfF7IuI130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP121379.RAemdQwDzVZh7gLMbPxLYNNiBsI2mha62xCPOSbfF7IuI130_provenance.
NP126143.RAeloF3l5_8jvXF5dczYFrFGjYWKb-Z0KX6_Z7922cbOQ130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP126143.RAeloF3l5_8jvXF5dczYFrFGjYWKb-Z0KX6_Z7922cbOQ130_provenance.
NP135747.RAaGV4X0UtRO-gJV1xGIqWFi4eUBQASB4yBx_1eC84HRA130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP135747.RAaGV4X0UtRO-gJV1xGIqWFi4eUBQASB4yBx_1eC84HRA130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP101811.RAnPexBpy6TQUXlpb38adSz0cOXAICu_5W057AFcYRyMo130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101811.RAnPexBpy6TQUXlpb38adSz0cOXAICu_5W057AFcYRyMo130_provenance.
NP101826.RAnSxDxSYmrUoVnXMMKThcDSGYYINj41aNg3YlqgvX7QI130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP101826.RAnSxDxSYmrUoVnXMMKThcDSGYYINj41aNg3YlqgvX7QI130_provenance.
NP118135.RAiBpbxsfNShutT_OqCODqsaD4J4h-nyN4hhAr1scOJ2w130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118135.RAiBpbxsfNShutT_OqCODqsaD4J4h-nyN4hhAr1scOJ2w130_provenance.
NP118193.RAhbP8fHxePQhefVuOHPB6T8NUOCcmk_mRnwsGeglyakc130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP118193.RAhbP8fHxePQhefVuOHPB6T8NUOCcmk_mRnwsGeglyakc130_provenance.
assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
NP187388.RAQITE4ByKyaZbYWsdUfq9iuttNWCVC3CDiOvVkyysUgA130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187388.RAQITE4ByKyaZbYWsdUfq9iuttNWCVC3CDiOvVkyysUgA130_provenance.
NP187390.RAfWYaaJD7-jXab6YPhOMpiEwyBGPuhzDKXSVvvmGIzGE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187390.RAfWYaaJD7-jXab6YPhOMpiEwyBGPuhzDKXSVvvmGIzGE130_provenance.
NP187393.RAfm_sp0qFBsM-956bDFg87cfss0WHnXY94OsjzCNXKrA130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187393.RAfm_sp0qFBsM-956bDFg87cfss0WHnXY94OsjzCNXKrA130_provenance.
NP187396.RAXLReSkjf9eSxnZEPYQbAyuiGJqQZvK9xmvISbblciys130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187396.RAXLReSkjf9eSxnZEPYQbAyuiGJqQZvK9xmvISbblciys130_provenance.
NP187403.RAXINTFMmiKs8nHEPpZm88iZqqOt9kH66SfWnFhKFh-VE130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187403.RAXINTFMmiKs8nHEPpZm88iZqqOt9kH66SfWnFhKFh-VE130_provenance.
NP187406.RAVV_v-DT7wIr1KfdA2Crt2xVaK1IrDy63w2izJ84ylDw130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187406.RAVV_v-DT7wIr1KfdA2Crt2xVaK1IrDy63w2izJ84ylDw130_provenance.
NP187407.RAR7U7IpUWGvqn5-EOjOYjI-YXP6y_ogaHQuZqnrglyms130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187407.RAR7U7IpUWGvqn5-EOjOYjI-YXP6y_ogaHQuZqnrglyms130_provenance.
NP187409.RAbnzlb1_ZK9YD5pXKsNis_2A58yBNKBA4w0fNVvqlrdc130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187409.RAbnzlb1_ZK9YD5pXKsNis_2A58yBNKBA4w0fNVvqlrdc130_provenance.
NP187414.RATMX1rMu_bYIVtr_xlVAdcLXjJy-rb3vdgzhwGWE4Wc4130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187414.RATMX1rMu_bYIVtr_xlVAdcLXjJy-rb3vdgzhwGWE4Wc4130_provenance.
NP187418.RAdkbmv87QValCVX94sqkRUoRoFhEafCb6BBZ6b1GOKVY130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187418.RAdkbmv87QValCVX94sqkRUoRoFhEafCb6BBZ6b1GOKVY130_provenance.
NP187419.RAZgmQ8dApsuT4T_7-AOihS_HueDkq9EZqNZ2ARJhlUbA130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187419.RAZgmQ8dApsuT4T_7-AOihS_HueDkq9EZqNZ2ARJhlUbA130_provenance.
NP187421.RASTqAklUkmgpTJBHuZPZ4FRSb00tLXREz6bfFNPoXo_M130_assertion description "[The IFNG (IFN-gamma) genotype predicts cytogenetic and molecular response to imatinib therapy in chronic myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP187421.RASTqAklUkmgpTJBHuZPZ4FRSb00tLXREz6bfFNPoXo_M130_provenance.